Rahul Singhvi

Rahul Singhvi is a declared insider at 2 companies; the most frequent names are Codexis, Inc. and Kairos Pharma, Ltd. Between 28 September 2022 and 8 October 2025, the trades on record add up to 5 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 26 November 2025, reports a share grant in Kairos Pharma, Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.